← Open Payments lookup

BARRY FENTON: Open Payments

NPI 1417082892 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,079 in 56 payments from 16 companies in 2025. Trend: 2023 $1,396 · 2024 $1,049 · 2025 $1,079

Food & beverage: $1,079
CompanyPaymentsAmount
ABBVIE INC.21$205
Axsome Therapeutics, Inc.6$191
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$135
Vanda Pharmaceuticals Inc.3$96
Alkermes, Inc.2$60
Corium, LLC2$59
E.R. Squibb & Sons, L.L.C.3$57
Neos Therapeutics, LP3$50
Tris Pharma Inc2$49
Lundbeck LLC2$43

Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, Azstarys, COBENFY, Adzenys XR-ODT.

Industry payments across TX — which companies pay providers there.